Evidence map›Paper›PMID 41330928›Full record

ArticleNature communications2025

Genomic surveillance uncovers regional variation in HCV transmission networks in rural United States.

Damien C Tully, David J Bean, Jacklyn Sarette, Thang Long Ngo, Karen A Power, Daniel Brook, Hannah Cooper, Judith Feinberg, Peter D Friedmann, Karli R Hochstatter and 14 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Damien C TullyMedical Research Council/Uganda Virus Research Institute and LSHTM Uganda Research Unit, Entebbe, Uganda. damien.tully@lshtm.ac.uk.ORCID http://orcid.org/0000-0002-7620-9340
David J BeanRagon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Jacklyn SaretteRagon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Thang Long NgoRagon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Karen A PowerRagon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Daniel BrookDivision of Epidemiology, College of Public Health, Ohio State University, Columbus, OH, USA.
Hannah CooperDepartment of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Judith FeinbergDepartments of Behavioral Medicine and Psychiatry and Medicine/Infectious Diseases, West Virginia University School of Medicine, Morgantown, WV, USA.
Peter D FriedmannUniversity of Massachusetts Chan Medical School - Baystate and Baystate Health, Springfield, MA, USA.ORCID http://orcid.org/0000-0003-3585-3604
Karli R HochstatterFriends Research Institute, Baltimore, ML, USA.
Jennifer R HavensDepartment of Behavioral Science, Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, KY, USA.
Shanna BabalonisDepartment of Behavioral Science, Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, KY, USA.
Christopher HurtInstitute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Wiley JenkinsDepartment of Public Health Sciences, Clemson University, Clemson, SC, USA.
P Todd KorthuisOregon Health & Science University, Portland, OR, USA.
William MillerThe Ohio State University, Columbus, OH, USA.ORCID http://orcid.org/0000-0002-1934-7827
Mai T PhoSection of Infectious Diseases and Global Health, Department of Medicine, University of Chicago, Chicago, IL, USA.
Gordon SmithSchool of Public Health, West Virginia University, Morgantown, WV, USA.ORCID http://orcid.org/0000-0002-2911-3071
Thomas J StopkaDepartment of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, USA.
Judith I TsuiDepartment of Medicine, School of Medicine, University of Washington, Seattle, WA, USA.
L Sarah MixsonDepartment of Medicine, School of Medicine, University of Washington, Seattle, WA, USA.
Ryan P WestergaardDivision of Infectious Diseases, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
April M YoungDepartment of Epidemiology and Environmental Health, University of Kentucky, Lexington, KY, USA.
Todd M AllenRagon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.

Funding

Increasing Access to Hepatitis C Treatment in Opioid Endemic Rural Areas: the Kentucky Viral Hepatitis Treatment (KeY Treat) StudyR01DA047952 · NIDA · UNIVERSITY OF KENTUCKY · PI HAVENS, JENNIFER R · 2018 to 2023
$8.7M
Examining the Impact of the Twin Epidemics of Methamphetamine and Opioid Use on Overdose, Risky Sex and Treatment Engagement among PWUD in Two Rural Appalachian CohortsR01DA033862 · NIDA · UNIVERSITY OF KENTUCKY · PI Jennifer R Havens · 2012 to 2026
$6.9M
Rural Comorbidity and HIV consequences of Opioid use Research and Treatment Initiative (Rural cohort)U24DA048538 · NIDA · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., TSUI, JUDITH · 2019 to 2023
$3.7M
Next-Generation Sequencing Center for GHOSTing Hepatitis C Virus: Transforming Community Based Molecular Surveillance and Outbreak InvestigationU24DA044801 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI ALLEN, TODD M · 2017 to 2022
$3.3M
Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)UG3DA044830 · NIDA · BAYSTATE MEDICAL CENTER, INC. · PI FRIEDMANN, PETER D · 2017 to 2018
$1.6M
Community-based, client-centered prevention homes to address the rural opioid epidemicUG3DA044826 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI SEAL, DAVID W, WESTERGAARD, RYAN PATRICK · 2017 to 2018
$1.4M
Kentucky Communities & Researchers Engaging to Halt the Opioid Epidemic-CARE2HOPEUG3DA044798 · NIDA · UNIVERSITY OF KENTUCKY · PI COOPER, HANNAH LF, YOUNG, APRIL MARIE · 2017 to 2018
$1.3M
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) StudyUG3DA044831 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KORTHUIS, PHILIP TODD · 2017 to 2018
$895k
NIDA NIH HHS R01 DA033862NIDA NIH HHS R01 DA047952NIDA NIH HHS U24 DA044801NIDA NIH HHS U24 DA048538NIDA NIH HHS UG3 DA044798NIDA NIH HHS UG3 DA044826NIDA NIH HHS UG3 DA044830NIDA NIH HHS UG3 DA044831U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) U24DA044801
6 · The paper itself

Abstract

Hepatitis C virus (HCV) remains a public health concern in the United States, particularly in rural communities where the opioid epidemic accelerates transmission among people who use drugs (PWUD). Despite this growing burden, the genetic features and transmission dynamics of HCV in these settings are poorly understood. We analyze 692 HCV antibody-positive specimens collected from rural communities in ten U.S. states using amplicon-based deep sequencing and the Global Hepatitis Outbreak and Surveillance Technology (GHOST) platform to reconstruct transmission networks. Among sequenced individuals, 29.5% are linked within clusters. Cluster structure varies by region from sparse networks in Ohio to dense clusters in New England and phylogenetic analyses show that some networks persist for over a decade, indicating sustained transmission. Nearly half of all clusters involve individuals connected through social recruitment, suggesting peer-referral strategies effectively identify transmission chains. Penalized regression retains only a few individual factors including younger age, peer or partner recruitment, illegal income, methamphetamine use, each with modest effects. These findings suggest that clustering is shaped primarily by social and structural contexts rather than individual characteristics and underscore the importance of integrating genomic surveillance with social-network insights to detect emerging HCV clusters and guide targeted interventions in underserved rural communities.

Indexed as

HepacivirusHepatitis CAdultFemaleGenomicsHumansMaleMiddle AgedPhylogenyRural PopulationUnited StatesYoung Adult

Identifiers

PMID41330928
PMCPMC12783787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.